⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OBIO News
Orchestra BioMed Holdings, Inc. Ordinary Shares
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
globenewswire.com
OBIO
MDT
Form 8-K
sec.gov
OBIO
Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
globenewswire.com
OBIO
MDT
Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026
globenewswire.com
OBIO
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
globenewswire.com
OBIO
HAE
Form 8-K
sec.gov
OBIO
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OBIO
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
OBIO
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference
globenewswire.com
OBIO
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
globenewswire.com
OBIO
MDT